These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 35224406)

  • 21. Mechanistic insights into SARS-CoV-2 epidemic via revealing the features of SARS-CoV-2 coding proteins and host responses upon its infection.
    Qin S; Xia X; Shi X; Ji X; Ma F; Chen L
    Bioinformatics; 2021 Jan; 36(21):5133-5138. PubMed ID: 32805023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure-Based Discovery and Structural Basis of a Novel Broad-Spectrum Natural Product against the Main Protease of Coronavirus.
    Zhang Y; Gao H; Hu X; Wang Q; Zhong F; Zhou X; Lin C; Yang Y; Wei J; Du W; Huang H; Zhou H; He W; Zhang H; Zhang Y; McCormick PJ; Fu J; Wang D; Fu Y; Lu X; Zhang T; Duan J; Qin B; Jiang H; Luo J; Zhang Y; Chen Q; Luo Q; Cheng L; Zhang Z; Zhang J; Li J
    J Virol; 2022 Jan; 96(1):e0125321. PubMed ID: 34586857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mapping SARS-CoV-2 Antibody Epitopes in COVID-19 Patients with a Multi-Coronavirus Protein Microarray.
    Camerini D; Randall AZ; Trappl-Kimmons K; Oberai A; Hung C; Edgar J; Shandling A; Huynh V; Teng AA; Hermanson G; Pablo JV; Stumpf MM; Lester SN; Harcourt J; Tamin A; Rasheed M; Thornburg NJ; Satheshkumar PS; Liang X; Kennedy RB; Yee A; Townsend M; Campo JJ
    Microbiol Spectr; 2021 Oct; 9(2):e0141621. PubMed ID: 34704808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of SARS-CoV-2 by Highly Potent Broad-Spectrum Anti-Coronaviral Tylophorine-Based Derivatives.
    Yang CW; Lee YZ; Hsu HY; Jan JT; Lin YL; Chang SY; Peng TT; Yang RB; Liang JJ; Liao CC; Chao TL; Pang YH; Kao HC; Huang WZ; Lin JH; Chang CP; Niu GH; Wu SH; Sytwu HK; Chen CT; Lee SJ
    Front Pharmacol; 2020; 11():606097. PubMed ID: 33519469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Previous viral symptoms and individual mothers influenced the leveled duration of human milk antibodies cross-reactive to S1 and S2 subunits from SARS-CoV-2, HCoV-229E, and HCoV-OC43.
    Demers-Mathieu V; DaPra C; Mathijssen GB; Medo E
    J Perinatol; 2021 May; 41(5):952-960. PubMed ID: 33649442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Crystal Structure of the SARS-CoV-2 Non-structural Protein 9, Nsp9.
    Littler DR; Gully BS; Colson RN; Rossjohn J
    iScience; 2020 Jul; 23(7):101258. PubMed ID: 32592996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SARS-CoV-2 mRNA vaccines induce broad CD4+ T cell responses that recognize SARS-CoV-2 variants and HCoV-NL63.
    Woldemeskel BA; Garliss CC; Blankson JN
    J Clin Invest; 2021 May; 131(10):. PubMed ID: 33822770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD4
    Taborska P; Strizova Z; Stakheev D; Sojka L; Bartunkova J; Smrz D
    Front Immunol; 2021; 12():629102. PubMed ID: 34012431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NSP9 of SARS-CoV-2 attenuates nuclear transport by hampering nucleoporin 62 dynamics and functions in host cells.
    Makiyama K; Hazawa M; Kobayashi A; Lim K; Voon DC; Wong RW
    Biochem Biophys Res Commun; 2022 Jan; 586():137-142. PubMed ID: 34844119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Susceptibilities of Human ACE2 Genetic Variants in Coronavirus Infection.
    Ren W; Zhu Y; Lan J; Chen H; Wang Y; Shi H; Feng F; Chen DY; Close B; Zhao X; Wu J; Tian B; Yuan Z; Zhou D; Saeed M; Wang X; Zhang R; Ding Q
    J Virol; 2022 Jan; 96(1):e0149221. PubMed ID: 34668773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The therapeutic promises of Lianhuaqingke in the mice model of coronavirus pneumonia (HCoV-229E and SARS-CoV-2).
    Wang M; Li W; Cui W; Hao Y; Mi Y; Wang H; Hou Y; Jia Z
    Chin Med; 2021 Oct; 16(1):104. PubMed ID: 34663385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reactive T Cells in Convalescent COVID-19 Patients With Negative SARS-CoV-2 Antibody Serology.
    Steiner S; Schwarz T; Corman VM; Sotzny F; Bauer S; Drosten C; Volk HD; Scheibenbogen C; Hanitsch LG
    Front Immunol; 2021; 12():687449. PubMed ID: 34322120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HCoV- and SARS-CoV-2 Cross-Reactive T Cells in CVID Patients.
    Steiner S; Sotzny F; Bauer S; Na IK; Schmueck-Henneresse M; Corman VM; Schwarz T; Drosten C; Wendering DJ; Behrends U; Volk HD; Scheibenbogen C; Hanitsch LG
    Front Immunol; 2020; 11():607918. PubMed ID: 33424856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pseudo-Dipeptide Bearing α,α-Difluoromethyl Ketone Moiety as Electrophilic Warhead with Activity against Coronaviruses.
    Citarella A; Gentile D; Rescifina A; Piperno A; Mognetti B; Gribaudo G; Sciortino MT; Holzer W; Pace V; Micale N
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genome-scale identification of SARS-CoV-2 and pan-coronavirus host factor networks.
    Schneider WM; Luna JM; Hoffmann HH; Sánchez-Rivera FJ; Leal AA; Ashbrook AW; Le Pen J; Michailidis E; Ricardo-Lax I; Peace A; Stenzel AF; Lowe SW; MacDonald MR; Rice CM; Poirier JT
    bioRxiv; 2020 Oct; ():. PubMed ID: 33052332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improved plaque assay for human coronaviruses 229E and OC43.
    Bracci N; Pan HC; Lehman C; Kehn-Hall K; Lin SC
    PeerJ; 2020; 8():e10639. PubMed ID: 33391888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protease Inhibitors: Candidate Drugs to Inhibit Severe Acute Respiratory Syndrome Coronavirus 2 Replication.
    Yamaya M; Nishimura H; Deng X; Kikuchi A; Nagatomi R
    Tohoku J Exp Med; 2020 May; 251(1):27-30. PubMed ID: 32448818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two serological approaches for detection of antibodies to SARS-CoV-2 in different scenarios: a screening tool and a point-of-care test.
    Hoste ACR; Venteo A; Fresco-Taboada A; Tapia I; Monedero A; López L; Jebbink MF; Pérez-Ramírez E; Jimenez-Clavero MA; Almonacid M; Muñoz P; Guinea J; Vela C; van der Hoek L; Rueda P; Sastre P
    Diagn Microbiol Infect Dis; 2020 Dec; 98(4):115167. PubMed ID: 32890908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Why the lower reported prevalence of asthma in patients diagnosed with COVID-19 validates repurposing EDTA solutions to prevent and manage treat COVID-19 disease.
    Cashman DP
    Med Hypotheses; 2020 Nov; 144():110027. PubMed ID: 32758873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Seroprevalence and SARS-CoV-2 cross-reactivity of endemic coronavirus OC43 and 229E antibodies in Finnish children and adults.
    Tamminen K; Salminen M; Blazevic V
    Clin Immunol; 2021 Aug; 229():108782. PubMed ID: 34118402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.